Prevalence and risk factors of preoperative venous thromboembolism in patients with malignant musculoskeletal tumors: an analysis based on D-dimer screening and imaging

Abstract Background Venous thromboembolism (VTE) is a major complication in patients with malignant tumors and orthopedic disorders. Although it is known that patients undergoing surgery for malignant musculoskeletal tumor are at an increased risk of thromboembolic events, only few studies have inve...

Full description

Bibliographic Details
Main Authors: Kenta Hayashida, Yusuke Kawabata, Keiju Saito, Shintaro Fujita, Hyonmin Choe, Ikuma Kato, Masanobu Takeyama, Yutaka Inaba
Format: Article
Language:English
Published: BMC 2022-04-01
Series:Thrombosis Journal
Subjects:
Online Access:https://doi.org/10.1186/s12959-022-00382-2
_version_ 1828839564287934464
author Kenta Hayashida
Yusuke Kawabata
Keiju Saito
Shintaro Fujita
Hyonmin Choe
Ikuma Kato
Masanobu Takeyama
Yutaka Inaba
author_facet Kenta Hayashida
Yusuke Kawabata
Keiju Saito
Shintaro Fujita
Hyonmin Choe
Ikuma Kato
Masanobu Takeyama
Yutaka Inaba
author_sort Kenta Hayashida
collection DOAJ
description Abstract Background Venous thromboembolism (VTE) is a major complication in patients with malignant tumors and orthopedic disorders. Although it is known that patients undergoing surgery for malignant musculoskeletal tumor are at an increased risk of thromboembolic events, only few studies have investigated this risk in detail. Therefore, the aim of this study was to determine the prevalence and risk factors for preoperative VTE in malignant musculoskeletal tumors patients. Methods We retrospectively reviewed the medical records of 270 patients who underwent surgical procedures, including biopsy for malignant musculoskeletal tumor, have undergone measurements of preoperative D-dimer levels, and were subsequently screened for VTE by lower extremity venous ultrasonography and/or contrast-enhanced computed tomography scans. Statistical analyses were performed to examine the prevalence and risk factors for VTE. Receiver operating characteristic (ROC) analysis was performed to verify the D-dimer cutoff value for the diagnosis of VTE. Results Overall, 199 patients (103 with primary soft tissue sarcomas, 38 with primary bone sarcomas, 46 with metastatic tumors, and 12 with hematologic malignancies) were included. D-dimer levels were high in 79 patients; VTE was detected in 19 patients (9.5%). Multivariate analysis indicated that age ≥ 60 years (P = 0.021) and tumor location in the lower limbs (P = 0.048) were independent risk factors for VTE. ROC analysis showed that the D-dimer cutoff value for the diagnosis of VTE was 1.53 µg/mL; the sensitivity and specificity were 89.5% and 79.4%, respectively. Conclusions Our study indicated that age and tumor location in the lower limbs were independent risk factors for preoperative VTE in malignant musculoskeletal tumors patients. D-dimer levels were not associated with VTE in the multivariate analysis, likely because they are affected by a wide variety of conditions, such as malignancy and aging. D-dimer is useful for exclusion diagnosis because of its high sensitivity, but patients with high age and tumor location in the lower limbs are a high-risk group and should be considered for imaging evaluation such as ultrasonography regardless of D-dimer levels. Trial registration Our study was approved by the institutional review board. The registration number is B200600056 . The registration date was July 13, 2020.
first_indexed 2024-12-12T19:25:25Z
format Article
id doaj.art-a9f374bf27454789b7d50a1ae42b04a1
institution Directory Open Access Journal
issn 1477-9560
language English
last_indexed 2024-12-12T19:25:25Z
publishDate 2022-04-01
publisher BMC
record_format Article
series Thrombosis Journal
spelling doaj.art-a9f374bf27454789b7d50a1ae42b04a12022-12-22T00:14:31ZengBMCThrombosis Journal1477-95602022-04-012011810.1186/s12959-022-00382-2Prevalence and risk factors of preoperative venous thromboembolism in patients with malignant musculoskeletal tumors: an analysis based on D-dimer screening and imagingKenta Hayashida0Yusuke Kawabata1Keiju Saito2Shintaro Fujita3Hyonmin Choe4Ikuma Kato5Masanobu Takeyama6Yutaka Inaba7Department of Orthopaedic Surgery, Yokohama City UniversityDepartment of Orthopaedic Surgery, Yokohama City UniversityDepartment of Orthopaedic Surgery, Yokohama City UniversityDepartment of Orthopaedic Surgery, Yokohama City UniversityDepartment of Orthopaedic Surgery, Yokohama City UniversityDepartment of Molecular Pathology, Yokohama City UniversityDepartment of Orthopaedic Surgery, Yokohama City UniversityDepartment of Orthopaedic Surgery, Yokohama City UniversityAbstract Background Venous thromboembolism (VTE) is a major complication in patients with malignant tumors and orthopedic disorders. Although it is known that patients undergoing surgery for malignant musculoskeletal tumor are at an increased risk of thromboembolic events, only few studies have investigated this risk in detail. Therefore, the aim of this study was to determine the prevalence and risk factors for preoperative VTE in malignant musculoskeletal tumors patients. Methods We retrospectively reviewed the medical records of 270 patients who underwent surgical procedures, including biopsy for malignant musculoskeletal tumor, have undergone measurements of preoperative D-dimer levels, and were subsequently screened for VTE by lower extremity venous ultrasonography and/or contrast-enhanced computed tomography scans. Statistical analyses were performed to examine the prevalence and risk factors for VTE. Receiver operating characteristic (ROC) analysis was performed to verify the D-dimer cutoff value for the diagnosis of VTE. Results Overall, 199 patients (103 with primary soft tissue sarcomas, 38 with primary bone sarcomas, 46 with metastatic tumors, and 12 with hematologic malignancies) were included. D-dimer levels were high in 79 patients; VTE was detected in 19 patients (9.5%). Multivariate analysis indicated that age ≥ 60 years (P = 0.021) and tumor location in the lower limbs (P = 0.048) were independent risk factors for VTE. ROC analysis showed that the D-dimer cutoff value for the diagnosis of VTE was 1.53 µg/mL; the sensitivity and specificity were 89.5% and 79.4%, respectively. Conclusions Our study indicated that age and tumor location in the lower limbs were independent risk factors for preoperative VTE in malignant musculoskeletal tumors patients. D-dimer levels were not associated with VTE in the multivariate analysis, likely because they are affected by a wide variety of conditions, such as malignancy and aging. D-dimer is useful for exclusion diagnosis because of its high sensitivity, but patients with high age and tumor location in the lower limbs are a high-risk group and should be considered for imaging evaluation such as ultrasonography regardless of D-dimer levels. Trial registration Our study was approved by the institutional review board. The registration number is B200600056 . The registration date was July 13, 2020.https://doi.org/10.1186/s12959-022-00382-2Preoperative venous thromboembolismVTEDeep vein thrombosisDVTMalignant musculoskeletal tumorMalignant musculoskeletal tumor
spellingShingle Kenta Hayashida
Yusuke Kawabata
Keiju Saito
Shintaro Fujita
Hyonmin Choe
Ikuma Kato
Masanobu Takeyama
Yutaka Inaba
Prevalence and risk factors of preoperative venous thromboembolism in patients with malignant musculoskeletal tumors: an analysis based on D-dimer screening and imaging
Thrombosis Journal
Preoperative venous thromboembolism
VTE
Deep vein thrombosis
DVT
Malignant musculoskeletal tumor
Malignant musculoskeletal tumor
title Prevalence and risk factors of preoperative venous thromboembolism in patients with malignant musculoskeletal tumors: an analysis based on D-dimer screening and imaging
title_full Prevalence and risk factors of preoperative venous thromboembolism in patients with malignant musculoskeletal tumors: an analysis based on D-dimer screening and imaging
title_fullStr Prevalence and risk factors of preoperative venous thromboembolism in patients with malignant musculoskeletal tumors: an analysis based on D-dimer screening and imaging
title_full_unstemmed Prevalence and risk factors of preoperative venous thromboembolism in patients with malignant musculoskeletal tumors: an analysis based on D-dimer screening and imaging
title_short Prevalence and risk factors of preoperative venous thromboembolism in patients with malignant musculoskeletal tumors: an analysis based on D-dimer screening and imaging
title_sort prevalence and risk factors of preoperative venous thromboembolism in patients with malignant musculoskeletal tumors an analysis based on d dimer screening and imaging
topic Preoperative venous thromboembolism
VTE
Deep vein thrombosis
DVT
Malignant musculoskeletal tumor
Malignant musculoskeletal tumor
url https://doi.org/10.1186/s12959-022-00382-2
work_keys_str_mv AT kentahayashida prevalenceandriskfactorsofpreoperativevenousthromboembolisminpatientswithmalignantmusculoskeletaltumorsananalysisbasedonddimerscreeningandimaging
AT yusukekawabata prevalenceandriskfactorsofpreoperativevenousthromboembolisminpatientswithmalignantmusculoskeletaltumorsananalysisbasedonddimerscreeningandimaging
AT keijusaito prevalenceandriskfactorsofpreoperativevenousthromboembolisminpatientswithmalignantmusculoskeletaltumorsananalysisbasedonddimerscreeningandimaging
AT shintarofujita prevalenceandriskfactorsofpreoperativevenousthromboembolisminpatientswithmalignantmusculoskeletaltumorsananalysisbasedonddimerscreeningandimaging
AT hyonminchoe prevalenceandriskfactorsofpreoperativevenousthromboembolisminpatientswithmalignantmusculoskeletaltumorsananalysisbasedonddimerscreeningandimaging
AT ikumakato prevalenceandriskfactorsofpreoperativevenousthromboembolisminpatientswithmalignantmusculoskeletaltumorsananalysisbasedonddimerscreeningandimaging
AT masanobutakeyama prevalenceandriskfactorsofpreoperativevenousthromboembolisminpatientswithmalignantmusculoskeletaltumorsananalysisbasedonddimerscreeningandimaging
AT yutakainaba prevalenceandriskfactorsofpreoperativevenousthromboembolisminpatientswithmalignantmusculoskeletaltumorsananalysisbasedonddimerscreeningandimaging